HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson Products going international with Carson backing.

This article was originally published in The Rose Sheet

Executive Summary

JOHNSON PRODUCTS WILL MOVE INTO INTERNATIONAL MARKETS established by new owner Carson, following the completion of the purchase of the ethnic personal care products business from IVX Bioscience (formerly Ivax). Johnson Products has minimal distribution outside the U.S., and its acquisition by Carson will change that, Acting CEO Vincent Wasik told a teleconference with securities analysts June 18. The firm will pursue an international strategy for Johnson, similar to that for Carson, that focuses on moving into international markets with few personal care offerings available for ethnic consumers, including South Africa and Brazil. The addition of Johnson's portfolio in the global market should give Carson a greater presence in areas the company claims are undiscovered by other marketers.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005532

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel